Sandbox Myopathy: Difference between revisions
Jump to navigation
Jump to search
Aditya Ganti (talk | contribs) |
Aditya Ganti (talk | contribs) No edit summary |
||
Line 115: | Line 115: | ||
* Phagocytic infiltration | * Phagocytic infiltration | ||
| | | | ||
* Normal | |||
|- | |- | ||
|Alcohol | |Alcohol | ||
Line 187: | Line 188: | ||
* + ACTH Stimulation test | * + ACTH Stimulation test | ||
* 24-hour urine [[cortisol]] | * 24-hour urine [[cortisol]] | ||
* Low dose [[dexamethasone]] | * Low dose [[dexamethasone]]<nowiki/>suppression test | ||
| | | | ||
* Normal | * Normal | ||
Line 400: | Line 401: | ||
* Perimysial mononuclear infiltrate | * Perimysial mononuclear infiltrate | ||
| rowspan="2" | | | rowspan="2" | | ||
* | * Myopathic | ||
|- | |- | ||
|Polymyositis<ref name="pmid16586492">{{cite journal| author=Dalakas MC| title=Polymyositis, dermatomyositis and inclusion-body myositis. | journal=N Engl J Med | year= 1991 | volume= 325 | issue= 21 | pages= 1487-98 | pmid=1658649 | doi=10.1056/NEJM199111213252107 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1658649 }}</ref> | |Polymyositis<ref name="pmid16586492">{{cite journal| author=Dalakas MC| title=Polymyositis, dermatomyositis and inclusion-body myositis. | journal=N Engl J Med | year= 1991 | volume= 325 | issue= 21 | pages= 1487-98 | pmid=1658649 | doi=10.1056/NEJM199111213252107 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1658649 }}</ref> | ||
Line 445: | Line 446: | ||
* Asymmetric weakness | * Asymmetric weakness | ||
| | | | ||
* Retrovirus most common | * Retrovirus most common | ||
| | | | ||
* N/A | |||
| | | | ||
* Antibodies to cytoplasmic 5'-nucleotidase | * Antibodies to cytoplasmic 5'-nucleotidase | ||
Line 468: | Line 470: | ||
| - | | - | ||
| - | | - | ||
| | | + | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
Line 523: | Line 525: | ||
|- | |- | ||
|Becker muscular dystrophy | |Becker muscular dystrophy | ||
|<13yrs | | | ||
* <13yrs | |||
| colspan="2" |Proximal | | colspan="2" |Proximal | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
Line 539: | Line 542: | ||
* Age of onset of symptoms is much delayed than duchenne | * Age of onset of symptoms is much delayed than duchenne | ||
| | | | ||
* +Grower sign | |||
| | | | ||
* Decreased amount of [[dystrophin]]. | * Decreased amount of [[dystrophin]]. | ||
Line 548: | Line 552: | ||
** Muscle replacement with fat and connective tissue | ** Muscle replacement with fat and connective tissue | ||
| rowspan="2" | | | rowspan="2" | | ||
* Myopathic | * Myopathic | ||
|- | |- | ||
|Duchenne muscular dystrophy | |Duchenne muscular dystrophy | ||
|<13 yrs | | | ||
* <13 yrs | |||
| colspan="2" | Proximal | | colspan="2" | Proximal | ||
| - | | - | ||
Line 571: | Line 576: | ||
| | | | ||
* Early onset | * Early onset | ||
| | | | ||
* +Grower sign | * +Grower sign | ||
Line 581: | Line 585: | ||
|- | |- | ||
|Limb-girdle muscular dystrophies | |Limb-girdle muscular dystrophies | ||
|<15 yrs | | | ||
* <15 yrs | |||
| colspan="2" |Proximal | | colspan="2" |Proximal | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
Line 588: | Line 593: | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| | |<nowiki>+</nowiki> | ||
| | |<nowiki>-</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| | | | ||
Line 600: | Line 605: | ||
| | | | ||
* Autosomal dominant | * Autosomal dominant | ||
* Deterioration of ability to run/walk | |||
| | | | ||
* | *Muscle weakness is generally symmetric, | ||
| | | | ||
* LMNA gene | * LMNA gene | ||
* CAV3 gene | * CAV3 gene | ||
| | | | ||
* '''↑↑''' | * '''↑↑''' | ||
Line 611: | Line 616: | ||
* - | * - | ||
| | | | ||
* Myopathic | |||
|- | |- | ||
|Myotonic dystrophy | |Myotonic dystrophy | ||
Line 624: | Line 630: | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| | |<nowiki>-</nowiki> | ||
| + | | + | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
Line 637: | Line 643: | ||
* Eyelid ptosis | * Eyelid ptosis | ||
| | | | ||
* +Family history | |||
| | | | ||
* Muscles often contract and are unable to relax | |||
| | | | ||
* Mutations in the DMPK gene | |||
| | | | ||
* - | |||
| | | | ||
* - | |||
| | | | ||
* Myopathic | |||
|- | |- | ||
! colspan="19" |Infectious | ! colspan="19" |Infectious | ||
|- | |- | ||
|Lyme disease | |Lyme disease | ||
|Variable | | | ||
* Variable | |||
| colspan="2" | | | colspan="2" | | ||
* Proximal | * Proximal | ||
Line 654: | Line 667: | ||
| +/- | | +/- | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
| | |<nowiki>-</nowiki> | ||
| | | - | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| | | | ||
Line 679: | Line 692: | ||
|- | |- | ||
|Infulenza | |Infulenza | ||
|Variable | | | ||
* Variable | |||
| colspan="2" | | | colspan="2" | | ||
* Negative | * Negative | ||
Line 687: | Line 701: | ||
| + | | + | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| | |<nowiki>-</nowiki> | ||
| | |<nowiki>-</nowiki> | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
| | | | ||
Line 696: | Line 710: | ||
* Muscle pain worse with movement | * Muscle pain worse with movement | ||
| | | | ||
* | *Cold weather | ||
*H/o Ill contacts | |||
| | | | ||
* Muscle weakness, tenderness, and swelling. | * Muscle weakness, tenderness, and swelling. | ||
Line 710: | Line 725: | ||
|- | |- | ||
|Polio | |Polio | ||
|<5 yrs | | | ||
* <5 yrs | |||
| colspan="2" | | | colspan="2" | | ||
* Proximal | * Proximal | ||
Line 719: | Line 735: | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
| | |<nowiki>-</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| | | | ||
Line 727: | Line 743: | ||
* [[Skeletal]] deformities | * [[Skeletal]] deformities | ||
| | | | ||
* History of skipped immunization. | |||
| | | | ||
* Normal | * Normal | ||
Line 743: | Line 760: | ||
|- | |- | ||
|Syphilis | |Syphilis | ||
|Variable | | | ||
* Variable | |||
| colspan="2" | | | colspan="2" | | ||
* Negative | * Negative | ||
Line 752: | Line 770: | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| | |<nowiki>-</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| | | | ||
Line 779: | Line 797: | ||
|- | |- | ||
|Pyomyositis | |Pyomyositis | ||
|Variable | | | ||
* Variable | |||
| colspan="2" | | | colspan="2" | | ||
* Proximal | * Proximal | ||
Line 821: | Line 840: | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| - | | - | ||
| | |<nowiki>-</nowiki> | ||
| | |<nowiki>+</nowiki> | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
| | |<nowiki>-</nowiki> | ||
| | | | ||
* Dysphagia | * Dysphagia | ||
Line 885: | Line 904: | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| | |<nowiki>-</nowiki> | ||
| | |<nowiki>+</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| | | | ||
Line 922: | Line 941: | ||
* Problems with speech or swallowing | * Problems with speech or swallowing | ||
| | | | ||
* Attacks or | * Attacks or exacerbation | ||
| | | | ||
** Localized weakness | ** Localized weakness | ||
Line 930: | Line 948: | ||
** Increased tone or stiffness | ** Increased tone or stiffness | ||
| | | | ||
* Head CT ologo-clonal bands | |||
| | | | ||
* Normal | |||
| | | | ||
* N/A | |||
| | | | ||
* Neuropathic | |||
|- | |- | ||
! colspan="19" |Neuro-muscular | ! colspan="19" |Neuro-muscular | ||
Line 941: | Line 963: | ||
| colspan="2" | | | colspan="2" | | ||
* Distal | * Distal | ||
| | |<nowiki>-</nowiki> | ||
| | |<nowiki>-</nowiki> | ||
| - | | - | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>+</nowiki> | |||
| - | |||
| | | | ||
* Double vision | |||
* Blurred vision | |||
* Drooping eyelids | |||
* Slurred speech | |||
* Difficulty swallowing | |||
| | | | ||
* H/O | * H/O food exposure | ||
| | | | ||
| | | | ||
Line 958: | Line 985: | ||
| | | | ||
|- | |- | ||
|Lambert-Eaton | |Lambert-Eaton syndome | ||
| | | | ||
* Variable | * Variable | ||
| colspan="2" | | | colspan="2" | | ||
* Distal | * Distal | ||
| | |<nowiki>-</nowiki> | ||
| | | - | ||
| - | | - | ||
|<nowiki>-</nowiki> | |||
| | | | ||
| | | | ||
Line 972: | Line 1,000: | ||
| | | | ||
| | | | ||
* Weaknessa is often relieved temporarily after exertion or physical exercise. | |||
* | |||
| | | | ||
| | | | ||
Line 985: | Line 1,012: | ||
| colspan="2" | | | colspan="2" | | ||
* Proximal | * Proximal | ||
| | |<nowiki>-</nowiki> | ||
| - | | - | ||
| | | + | ||
|<nowiki>+</nowiki> | |||
| | | | ||
| | | | ||
Line 1,001: | Line 1,028: | ||
* Isolated neck, limbs and respiratory weakness | * Isolated neck, limbs and respiratory weakness | ||
| | | | ||
| | | | ||
Line 1,069: | Line 1,074: | ||
|Mitochondrial | |Mitochondrial | ||
| | | | ||
| colspan="2" | | |||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | |
Revision as of 07:31, 8 April 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Flow chart
Objective Muscle weakness | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Malignancy Arthralgia Anemia Firbomyalgia | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Generalized | Localized | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Myasthenia gravis Periodic paralysis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Asymmetric | Symmetric | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cerebrovascular accidents Demyleinating disorders Atrophy Mononeuropathy | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Specific pattern | Specific pattern | Proximal | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hereditary neuropathy Muscular dystrophy | Myoapthy Duchenne muscular dystrophy | Motor neuron disease Peripheral neuropathy | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Differentiating Various Muscle Weakness
Disease | Symptoms | History | Physical
Examination |
Diagnosis | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Age of onset | Muscle weakness | Fever | Myalgia | Contractures | Gait abnormality | Neuropathy | Atrophy | Stiffness | Myoglobinuria | Other features | Laboratory Findings | Creatine Kinase | Muscle Biopsy | Electromyogram | ||||
Medications | ||||||||||||||||||
Corticosteroids |
|
|
- | + | - | - | - | + | - | - |
|
|
|
|
|
|
| |
Statins |
|
|
- | + | - | - | - | - | - | -/+(rhabdomyolysis) |
|
|
|
|
|
|
| |
Alcohol |
|
|
- | - | - | + | +/- | - | - | - |
|
|
|
|
|
|
| |
Endocrine | ||||||||||||||||||
Cushing's disease |
|
|
- | - | - | - | - | + | - | - |
|
|
|
|
|
|
Normal | |
Adrenal insufficiency |
|
|
- | + | - | - | - | - | + | - |
|
|
|
|
|
|
| |
Hyperaldosteronism with myopathy |
|
|
- | - | - | - | - | - | - | +
Rhabdomyolysis |
|
|
|
|
|
|
| |
Hyperthyroidism |
|
|
- | - | - | - | - | + | + | + |
|
|
|
|
|
|
| |
Hypothyroidism |
|
|
- | + | + | - | - | + | + | + Rhabdomyolysis |
|
|
|
|
|
|
| |
Diabetic infraction |
|
|
+ | + | - | - | + | + | - | - |
|
|
|
|
|
|
| |
Inflammatory / Rheumatologic | ||||||||||||||||||
Dermatomyositis[1] |
|
|
+ | + | - | - | - | - | + | - |
|
|
|
|
|
|
| |
Polymyositis[2] |
|
|
+ | + | - | - | - | - | + | - |
|
|
|
|
| |||
Inclusion body myositis[3] |
|
|
- | - | - | - | - | - | - | - |
|
|
|
|
|
|
| |
Fibomyalgia |
|
|
- | - | - | - | + | - | - | - |
|
|
|
|
|
|
| |
Polymyalgia Rheumatica[4] |
|
|
+ | + | - | - | - | - | + | - |
|
|
|
|
|
|
| |
Genetic | ||||||||||||||||||
Becker muscular dystrophy |
|
Proximal | - | - | + | + | - | + | - | - |
|
|
|
|
|
|
| |
Duchenne muscular dystrophy |
|
Proximal | - | - | + | + | - | + | - | - |
|
|
|
|
| |||
Limb-girdle muscular dystrophies |
|
Proximal | - | + | + | + | - | + | - | - |
|
|
|
|
|
|
| |
Myotonic dystrophy |
|
|
- | - | + | + | - | - | + | - |
|
|
|
|
|
|
| |
Infectious | ||||||||||||||||||
Lyme disease |
|
|
+ | + | - | +/- | + | - | - | - |
|
|
|
|
|
|
| |
Infulenza |
|
|
+ | + | - | + | - | - | - | + |
|
|
|
|
|
|
| |
Polio |
|
|
- | - | - | + | + | + | - | - |
|
|
|
|
|
|
| |
Syphilis |
|
|
- | - | - | + | + | - | - | - |
|
|
|
|
|
|
| |
Pyomyositis |
|
|
+ | + | - | - | - | - | + | - |
|
|
|
|
|
|
| |
Neurologic | ||||||||||||||||||
ALS |
|
|
- | - | - | - | + | + | + | - |
|
|
|
|
|
|
| |
Stroke |
|
|
- | - | - | + | + | + | - | - |
|
|
|
|
|
|
| |
GBS |
|
|
- | - | - | + | - | - | + | - |
|
|
|
|
|
|
| |
Multiple Sclerosis |
|
|
- | - | - | + | + | - | - | - |
|
|
|
|
|
|
| |
Neuro-muscular | ||||||||||||||||||
Botulisim |
|
|
- | - | - | + | - | - | + | - |
|
|
||||||
Lambert-Eaton syndome |
|
|
- | - | - | - |
|
|||||||||||
Myasthenia gravis |
|
|
- | - | + | + |
|
|||||||||||
Hereditary | ||||||||||||||||||
Glycogen storage disease |
|
|
- | - | - | - | - | - |
|
|
|
|
|
|
| |||
Mitochondrial |
- ↑ Dalakas MC (1991). "Polymyositis, dermatomyositis and inclusion-body myositis". N Engl J Med. 325 (21): 1487–98. doi:10.1056/NEJM199111213252107. PMID 1658649.
- ↑ Dalakas MC (1991). "Polymyositis, dermatomyositis and inclusion-body myositis". N Engl J Med. 325 (21): 1487–98. doi:10.1056/NEJM199111213252107. PMID 1658649.
- ↑ Dalakas MC (1991). "Polymyositis, dermatomyositis and inclusion-body myositis". N Engl J Med. 325 (21): 1487–98. doi:10.1056/NEJM199111213252107. PMID 1658649.
- ↑ Myklebust G, Gran JT (1996). "A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis". Br J Rheumatol. 35 (11): 1161–8. PMID 8948307.